Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
T Suda, N Takahashi, N Udagawa, E Jimi… - Endocrine …, 1999 - academic.oup.com
OSTEOCLASTS, which are present only in bone, are multinucleated giant cells with the
capacity to resorb mineralized tissues. During the past decade, several new approaches …
capacity to resorb mineralized tissues. During the past decade, several new approaches …
Paracrine and endocrine actions of bone—the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts
The skeleton is a dynamic organ that is constantly remodeled. Proteins secreted from bone
cells, namely osteoblasts, osteocytes, and osteoclasts exert regulation on …
cells, namely osteoblasts, osteocytes, and osteoclasts exert regulation on …
Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass
P Ducy, M Amling, S Takeda, M Priemel, AF Schilling… - Cell, 2000 - cell.com
Gonadal failure induces bone loss while obesity prevents it. This raises the possibility that
bone mass, body weight, and gonadal function are regulated by common pathways. To test …
bone mass, body weight, and gonadal function are regulated by common pathways. To test …
The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption
Although multiple hormones and cytokines regulate various aspects of osteoclast formation,
the final two effectors are osteoprotegerin ligand (OPG‐L)/osteoclast differentiation factor …
the final two effectors are osteoprotegerin ligand (OPG‐L)/osteoclast differentiation factor …
Receptor activator of nuclear factor κB ligand and osteoprotegerin regulation of bone remodeling in health and disease
Osteoclasts and osteoblasts dictate skeletal mass, structure, and strength via their respective
roles in resorbing and forming bone. Bone remodeling is a spatially coordinated lifelong …
roles in resorbing and forming bone. Bone remodeling is a spatially coordinated lifelong …
Osteoclasts: new insights
F Xu, SL Teitelbaum - Bone research, 2013 - nature.com
Osteoclasts, the bone-resorbing cells, play a pivotal role in skeletal development and adult
bone remodeling. They also participate in the pathogenesis of various bone disorders …
bone remodeling. They also participate in the pathogenesis of various bone disorders …
Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine …
LC Hofbauer, F Gori, BL Riggs, DL Lacey… - …, 1999 - academic.oup.com
Osteoporosis is a serious complication of systemic glucocorticoid use. However, while
glucocorticoids increase bone resorption in vitro and in vivo, the mechanism (s) of this effect …
glucocorticoids increase bone resorption in vitro and in vivo, the mechanism (s) of this effect …
Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors
F Arai, T Miyamoto, O Ohneda, T Inada… - The Journal of …, 1999 - rupress.org
Osteoclasts are terminally differentiated cells derived from hematopoietic stem cells.
However, how their precursor cells diverge from macrophagic lineages is not known. We …
However, how their precursor cells diverge from macrophagic lineages is not known. We …
Mechanisms of TNF-α–and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis
CT Ritchlin, SA Haas-Smith, P Li… - The Journal of …, 2003 - Am Soc Clin Investig
Psoriatic arthritis (PsA) is an inflammatory joint disease characterized by extensive bone
resorption. The mechanisms underlying this matrix loss have not been elucidated. We report …
resorption. The mechanisms underlying this matrix loss have not been elucidated. We report …
Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology
LC Hofbauer, AE Heufelder - Journal of molecular medicine, 2001 - Springer
Receptor activator of nuclear factor (NF-κB) ligand (RANKL), its cellular receptor, receptor
activator of NF-κB (RANK), and the decoy receptor osteoprotegerin (OPG) constitute a novel …
activator of NF-κB (RANK), and the decoy receptor osteoprotegerin (OPG) constitute a novel …